Disease/Infection News

RSS

COVID-19 induces the generation of distinct autoantibodies

In a recent study, the association between COVID-19 and autoimmunity is investigated at all levels of disease severity.

21 Sep 2021

Detecting early outcomes in COVID-19 patients

A new Nature study aimed to predict clinical data of COVID-19 patients based on clinical outcomes.

21 Sep 2021

Is the Pfizer-BioNTech COVID vaccine still effective after 6 months?

A team of researchers assessed the effectiveness of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine.

21 Sep 2021

Scientists identify potential therapeutic targets to alleviate severe COVID-19 in aged patients

The scientists assessed epidemiological data from March to December 2020 from the CDC to investigate the prevalence of COVID-19 disease among different age groups.

21 Sep 2021

Three US COVID-19 vaccines provide substantial protection against hospitalization

A new study reports that a head-to-head comparison of the efficacy of the three vaccines used in the USA indicates substantial protection against hospitalization with COVID-19 following vaccination with any of these vaccines.

21 Sep 2021

COVID-19 and the widening online information gap

A new study shows that digital access to information inequalities have further increased during this period, inevitably reflecting in health, education, and employment.

21 Sep 2021

The impact of the COVID-19 pandemic on access to vaccines during pregnancy

A new preprint discusses how women felt during the pandemic as they struggled to gain access to safe vaccination for themselves and for their babies.

21 Sep 2021

Scientists identify factors triggering COVID-19 vaccine hesitancy among healthcare workers

A team of US-based scientists has recently conducted a survey to determine the willingness of healthcare workers towards coronavirus disease 2019 (COVID-19) vaccinations.

21 Sep 2021

Could monitoring headaches after COVID-19 vaccination help identify rare cases of cerebral venous thrombosis?

Researchers from the Akershus University Hospital in Norway investigated 77 cases of CVT in vaccinated subjects to identify risks and warning signs to better predict these severe side effects.

21 Sep 2021

New cell-free antibody generation platform successfully creates neutralizing antibodies effective against SARS-CoV-2

Researchers from the Broad Institute of MIT and Harvard have created a cell-free nanobody engineering platform that can produce antibodies effectively and quickly.

21 Sep 2021

Decline in SARS-CoV-2 neutralizing antibodies and unique cytokine profile in severe COVID-19 patients

A new study has focused on antibody levels and cytokine profiles of COVID-19 patients with mild symptoms, pneumonia, and severe pneumonia.

21 Sep 2021

Neurokinin-1 receptor: a potential drug target for the treatment of COVID-19

An opinion article aims to provide evidence that SP could be the possible factor for initiating the cytokine storm during severe SARS-CoV-2 infection.

21 Sep 2021

Maintenance dialysis patients may need additional shots of COVID-19 vaccines

Researchers in the United States have conducted a study showing that the antibody response to vaccination designed to protect against coronavirus disease 2019 (COVID-19) wanes substantially over time among patients receiving maintenance dialysis.

21 Sep 2021

Count of severe COVID-19 no higher in children during second wave compared to first wave

Researchers in the UK have conducted a study suggesting that severe disease in children and young people admitted to hospital following infection with severe acute respiratory syndrome coronavirus (SARS-CoV-2) is still rare and was no more common during the second wave of infections than the first.

21 Sep 2021

Dynamics of innate immune responses decide COVID-19 severity in genetically diverse mice

In a recently published article on the bioRxiv* preprint server, scientists from the USA and UK have described the significance of early inflammatory signaling pathways in determining the severity of coronavirus disease 2019 (COVID-19).

21 Sep 2021

Changes in fibrin clot structure contributes to thrombosis risk in severe COVID-19

Researchers from Europe recently demonstrated altered levels of factor XII (FXII) and its activation products in 2 independent cohorts of critically ill patients with COVID-19 compared to patients suffering from severe acute respiratory distress syndrome caused by the influenza virus (acute respiratory distress syndrome (ARDS)-influenza).

21 Sep 2021

COVID-19 vaccine effectiveness against SARS-CoV-2 variants

A commentary published in the journal Cell summarizes international data on vaccine effectiveness against new severe acute respiratory coronavirus 2 (SARS-CoV-2) variants. Evidence shows that the currently approved vaccines continue to be effective in preventing severe and symptomatic illness — even with the widely circulating Delta variant.

21 Sep 2021

Dutch study shows COVID vaccines 97% effective in preventing ICU admission

Vaccinations help keep people out of the hospital, according to a new preprint medRxiv* study from researchers at the University of Amsterdam and the National Institute for Public Health and the Environment (RIVM) in the Netherlands.

21 Sep 2021

Scientists hypothesize SARS-CoV-2 cryptically circulating among humans before the current outbreak

As nations begin to recover, researchers from the National Taiwan University and Academia Sinica in Taipei have been looking to identify the changes the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) underwent over the course of the pandemic in order to better understand why the disease showed such virulence.

20 Sep 2021

Researchers identify prediction markers which can be used to define COVID-19 severity

An estimated 14−17% of hospitalized COVID-19 patients develop a severe form of the disease, requiring oxygen support and admission to the intensive care unit.

20 Sep 2021

Disease/Infection News

COVID-19 induces the generation of distinct autoantibodies

Detecting early outcomes in COVID-19 patients

Is the Pfizer-BioNTech COVID vaccine still effective after 6 months?

Scientists identify potential therapeutic targets to alleviate severe COVID-19 in aged patients

Three US COVID-19 vaccines provide substantial protection against hospitalization

COVID-19 and the widening online information gap

The impact of the COVID-19 pandemic on access to vaccines during pregnancy

Scientists identify factors triggering COVID-19 vaccine hesitancy among healthcare workers

Could monitoring headaches after COVID-19 vaccination help identify rare cases of cerebral venous thrombosis?

New cell-free antibody generation platform successfully creates neutralizing antibodies effective against SARS-CoV-2

Decline in SARS-CoV-2 neutralizing antibodies and unique cytokine profile in severe COVID-19 patients

Neurokinin-1 receptor: a potential drug target for the treatment of COVID-19

Maintenance dialysis patients may need additional shots of COVID-19 vaccines

Count of severe COVID-19 no higher in children during second wave compared to first wave

Dynamics of innate immune responses decide COVID-19 severity in genetically diverse mice

Changes in fibrin clot structure contributes to thrombosis risk in severe COVID-19

COVID-19 vaccine effectiveness against SARS-CoV-2 variants

Dutch study shows COVID vaccines 97% effective in preventing ICU admission

Scientists hypothesize SARS-CoV-2 cryptically circulating among humans before the current outbreak

Researchers identify prediction markers which can be used to define COVID-19 severity

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News